生物启发的miRNA-响应Ca2+纳米调节器具有双干扰途径和针对瘤向的线粒体功能障碍的自我放大级联
Jinkun Huang1, Qin Xiang1, Lei Shuai1
1Marshall Laboratory of Biomedical Engineering, Shenzhen Key Laboratory for Nano-Biosensing Technology, School of Biomedical Engineering, Medical School, Shenzhen University, Shenzhen 518060, China.
ACS nano
|December 11, 2025
概括
一种新型的纳米调节器通过破坏离子 (Ca2+) 稳态来精确地准瘤细胞,从而导致癌细胞死亡. 这一策略通过控制线粒体Ca2+过载,为癌症治疗提供了一种新方法.
科学领域:
- 生物医学工程 生物医学工程
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 线粒体离子 (Ca2+) 稳态破坏是关键的抗癌策略.
- 精确的时空控制线粒体Ca2+过载仍然是癌症治疗中的挑战.
研究的目的:
- 开发一种针对瘤特异性线粒体功能障碍的miRNA响应纳米调节器.
- 为了实现精确的时空控制线粒体Ca2+过载,用于癌症治疗.
主要方法:
- DNA酶 (Dz) 与铜氧化物 (Cu2O) 纳米颗粒的结合,形成Cu2O@Dz.
- 利用瘤微环境的酸度和H2O2来通过芬顿式反应产生基基 (•OH).
- 采用DZ作为双模式生物传感器执行器用于miRNA-21检测和miRNA-25裂变,以调节线粒体单载体 (MCU).
主要成果:
- Cu2O@Dz通过编排内源性离子流来诱导瘤特异性的线粒体功能障碍.
- TRPA1通道的激活导致了细胞外Ca2+的流入,而miRNA-25裂变促进了线粒体Ca2+的吸收.
- 协同的Ca2+过载导致了强大的瘤细胞亡.
结论:
- Cu2O@Dz纳米调节器使双离子干扰路径的有效时空协调成为精确准的目标.
- 该平台为精密瘤学中病态离子流的器官特异调制提供了一个多功能框架.
- 这项研究表明,通过诱导不可逆转的线粒体Ca2+过载,它具有强大的抗癌策略.
相关概念视频
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K


